Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer

Chimeric Antigen Receptor T-Cell Therapy for Colorectal Cancer

Chimeric antigen receptor (CAR) T-cell therapy represents a new genetically engineered method of immunotherapy for cancer. The patient’s T-cells are modified to express a specific receptor that sticks to the tumor antigen. This modified cell is then reintroduced into the patient’...

Full description

Bibliographic Details
Main Authors: Daniel Sur, Andrei Havasi, Calin Cainap, Gabriel Samasca, Claudia Burz, Ovidiu Balacescu, Iulia Lupan, Diana Deleanu, Alexandru Irimie
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Journal of Clinical Medicine
Subjects:
chimeric antigen receptor (car)t-cell
colorectal cancer
immunotherapy
toxicity
trials
Online Access:https://www.mdpi.com/2077-0383/9/1/182

Internet

https://www.mdpi.com/2077-0383/9/1/182

Similar Items